Laser photocoagulation, adjuvant bevacizumab preserve contrast in eyes with PDR

Intravitreal bevacizumab injections appeared to mitigate loss of contrast sensitivity resulting from panretinal photocoagulation in eyes with high-risk proliferative diabetic retinopathy, according to a study.The prospective, randomized study included 70 eyes of 35 patients with high-risk proliferative diabetic retinopathy; 35 eyes underwent panretinal photocoagulation (PRP) alone, and 35 eyes underwent PRP with adjuvant intravitreal injections of Avastin (bevacizumab, Genentech). Mean patient age was 56 years.

Full Story →